Brexit transition period was completed on 31 December 2020 and the United Kingdom is no longer part of the European Union. This means that there will be changes for biocidal product authorisations and Biocidal Active Substance approvals, as the Biocidal Product Regulation in its adopted version only applies to the European Union. This means, that – if your company is present on the UK market with active chlorine generated from sodium chloride by electrolysis – you need a separate product authorisation according to UK BPR. Latest news reports the withdrawal of the active substance approval dossier for “active chlorine generated from sodium chloride by electrolysis” in the UK.
HSE (the UK Authority for BPR) published an open invitation to provide an opportunity for a person, company or task force/consortium to notify an intention to take up or take over the role of participant in the GB Review Programme for “active chlorine generated from sodium chloride by electrolysis” in product types 2, 3, 4 and 5. A corresponding notification is due until 12 August 2023. If a notification to take over the role of participant is not received, these active substance/product type combinations will be subject to a GB non-approval decision. Biocidal products containing active substances with GB non-approval decisions for the relevant product types will have to be removed from the GB market.
Please note that ISA Consortium will not be directly initiating any active substance approval procedures or future product authorisations in the UK.
Therefore, please state you interest in a joined task force dedicated to that topic as soon as possible to firstname.lastname@example.org.